NEO Latest Press Releases

-- October 28, 2026 --

NeoGenomics Reports Third Quarter 2026 Results Business Wire 4:05 PM

-- October 15, 2026 --

NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology Business Wire 7:05 AM

-- October 14, 2026 --

NeoGenomics to Report Third Quarter 2026 Financial Results on October 28, 2026 Business Wire 7:05 AM

-- October 5, 2026 --

NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan Business Wire 4:05 PM

-- September 1, 2026 --

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Business Wire 7:05 AM

-- August 26, 2026 --

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring Business Wire 4:17 PM

-- July 28, 2026 --

NeoGenomics Reports Second Quarter 2026 Results Business Wire 4:05 PM

-- July 20, 2026 --

NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS Business Wire 5:23 PM

-- July 9, 2026 --

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer Business Wire 7:05 AM

-- July 7, 2026 --

NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 Business Wire 7:05 AM

-- June 25, 2026 --

NeoGenomics Appoints Carolyn Starrett to its Board of Directors Business Wire 7:05 AM

-- June 17, 2026 --

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes Business Wire 6:00 AM

-- June 15, 2026 --

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes Business Wire 5:24 PM

Market Data Delayed 15 Minutes